Katriina Vuolteenaho

Activities

Activities per year 1999 2009 2010 2011 2012 2013 2016 2017 2018 2023

• 160 Conference presentation
• 16 Invited lecture
• 10 Reviewer of Scientific Journal
• 7 Position of trust in an academic community
• 22 More
  • 6 Regular membership of a society or network
  • 4 Pre-examination of dissertation or acting as opponent to doctoral students
  • 4 Supervisor of licentiate candidate in medicine
  • 2 Supervisor of doctoral candidate
  • 2 Supervisor of licentiate candidate
  • 2 Position of trust in a funding organization
  • 1 Statement of assessment of docentship
  • 1 Supervisor of master student

Activities per year

Search results

• Association of adipokines adipsin, resistin and leptin with interleukin 6 and metalloproteinases 1 and 3 in synovial fluid from osteoarthritis patients

  Koskinen, A. (Speaker), Vuolteenaho, K. (Speaker), Nieminen, R. (Speaker), Moilanen, T. (Speaker) & Moilanen, E. (Speaker)

  27 Jan 2012

  Activity: Talk or presentation › Conference presentation

• Adiponectin is associated with joint inflammation and cartilage degradation in osteoarthritis

  Koskinen, A. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  7 Nov 2011

  Activity: Talk or presentation › Conference presentation

• Adipokines leptin and adiponectin correlate with matrix metalloproteinases and interleukin-6 in synovial fluid from osteoarthritis patients and enhance their production in osteoarthritic cartilage ex vivo

  Vuolteenaho, K. (Contributor), Koskinen, A. (Contributor), Juslin, S. (Contributor), Nieminen, R. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  7 Nov 2011

  Activity: Talk or presentation › Conference presentation

• Adiponectin is associted with joint inflammation and cartilage degradation in osteoarthritis

  Koskinen, A. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  26 Jun 2011

  Activity: Talk or presentation › Conference presentation

• Adiponectin as a catabolic factor in OA. Adiponectin correlates with circulating COMP and MMP-3, and increases production of MMP-3, nitric oxide and IL-6 in human OA cartilage

  Vuolteenaho, K. (Contributor), Moilanen, E. (Contributor) & Nieminen, R. (Contributor)

  25 Mar 2011

  Activity: Talk or presentation › Conference presentation

• Proinflammatory and catabolic role of adipokines leptin and adiponectin in arthritis

  Koskinen, A. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  25 Mar 2011

  Activity: Talk or presentation › Conference presentation

• Proinflammatory and catabolic role of adipokines leptin and adiponectin in arthritis

  Koskinen, A. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  10 Feb 2011

  Activity: Talk or presentation › Conference presentation

• High leptin concentrations and low SOCS-3 expression are associated with increased MMP levels in obese osteoarthritis patients

  Vuolteenaho, K. (Speaker), Koskinen, A. (Speaker), Moilanen, E. (Speaker) & Nieminen, R. (Speaker)

  28 Jan 2011

  Activity: Talk or presentation › Conference presentation

• Plasma adiponectin is associated with radiographic knee osteoarthritis, and cartilage adiponectin production correlates with nitric oxide, IL-6 and MMP-3

  Koskinen, A. (Speaker), Vuolteenaho, K. (Speaker), Juslin, S. (Speaker), Nieminen, R. (Speaker), Moilanen, T. (Speaker) & Moilanen, E. (Speaker)

  28 Jan 2011

  Activity: Talk or presentation › Conference presentation

• Proinflammatory and catabolic role of leptin in osteoarthritis. Correlation with IL-6, MMP-1 and MMP-3 in synovial fluid and effects in human OA cartilage

  Koskinen, A. (Speaker), Moilanen, E. (Speaker), Nieminen, R. (Speaker) & Vuolteenaho, K. (Speaker)

  24 Sept 2010

  Activity: Talk or presentation › Conference presentation

• Leptin as a catabolic factor in osteoarthritis. Correlation with MMP-1 and MMP-3 in synovial fluid and effects on MMP production in human OA cartilage

  Koskinen, A. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  30 Aug 2010

  Activity: Talk or presentation › Conference presentation

• Proinflammatory and catabolic role of adipokines leptin and adiponectin in arthritis

  Vuolteenaho, K. (Contributor), Koskinen, A. (Contributor), Moilanen, E. (Contributor) & Nieminen, R. (Contributor)

  17 Jul 2010

  Activity: Talk or presentation › Conference presentation

• Predictive value of pretreatment adipocytokine levels for remission rates in early RA treated with DMARDs and infliximab

  Vuolteenaho, K. (Contributor) & Nieminen, R. (Contributor)

  17 Jul 2010

  Activity: Talk or presentation › Conference presentation

• Catabolic role of leptin in osteoarthritis. Correlation with MMP-1 and MMP-3 in synovial fluid from OA patients and effects on human OA cartilage

  Koskinen, A. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  25 Mar 2010

  Activity: Talk or presentation › Conference presentation

• Destructive role of leptin in osteoarthritis Correlation with MMP-1 and MMP-3 in synovial fluid from OA patients and effects in human OA cartilage

  Koskinen, A. (Speaker), Moilanen, E. (Speaker), Nieminen, R. (Speaker) & Vuolteenaho, K. (Speaker)

  28 Jan 2010

  Activity: Talk or presentation › Conference presentation

• Resistin is linked to inflammation and metabolic syndrome in women with inflammatory arthritis

  Kontunen, P. (Speaker), Vuolteenaho, K. (Speaker), Nieminen, R. (Speaker), Kautiainen, H. (Speaker), Kauppi, M. (Speaker), Hakala, M. (Speaker) & Moilanen, E. (Speaker)

  28 Jan 2010

  Activity: Talk or presentation › Conference presentation

• Adiponectin as a catabolic factor in OA correlation to OA biomarkers comp and MMP-3, and effects on no, MMP-3 and IL-6 production in human OA cartilage

  Juslin, S. (Speaker), Vuolteenaho, K. (Speaker), Nieminen, R. (Speaker), Moilanen, T. (Speaker) & Moilanen, E. (Speaker)

  28 Jan 2010

  Activity: Talk or presentation › Conference presentation

• Resistin is linked to inflammation and metabolic syndrome in women with inflammatory arthritis

  Kontunen, P. (Contributor), Vuolteenaho, K. (Contributor), Nieminen, R. (Contributor), Kautiainen, H. (Contributor), Kauppi, M. (Contributor), Hakala, M. (Contributor) & Moilanen, E. (Contributor)

  20 Jan 2010

  Activity: Talk or presentation › Conference presentation

• Correlation with MMP and MMP3 in synovial fluid from OA patients and effects in human OA cartilage

  Koskinen, A. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  20 Jan 2010

  Activity: Talk or presentation › Conference presentation

• Adiponectin as a detrimental factor in OA. Correlation with biomarkers of OA, COMP and MMP-3 in male OA patients and effects on NO, MMP-3 and IL6 production in human OA cartilage

  Vuolteenaho, K. (Contributor), Moilanen, E. (Contributor) & Nieminen, R. (Contributor)

  20 Jan 2010

  Activity: Talk or presentation › Conference presentation

• Adiponectin as a catabolic factor in OA. Adiponectin correlates with circulating COMP and MMP-3, and increases production of MMP-3, nitric oxide and IL-6 in human OA cartilage

  Vuolteenaho, K. (Contributor), Moilanen, E. (Contributor) & Nieminen, R. (Contributor)

  11 Sept 2009

  Activity: Talk or presentation › Conference presentation

• Infliximab treatment in patients with rheumatoid arthritis and spondylarthropathies two years drug survival

  Levälampi, T. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  7 Jul 2009

  Activity: Talk or presentation › Conference presentation

• Leptin enhances MMP-1, MMP-3 and MMP-13 production in human OA cartilage

  Vuolteenaho, K. (Contributor), Koskinen, A. (Contributor), Kukkonen, M. (Contributor), Nieminen, R. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  20 Mar 2009

  Activity: Talk or presentation › Conference presentation

• Pretreatment levels of adipokines adipsin and leptin are associated with remission rates in early RA (NEO-RaCo study)

  Moilanen, E. (Contributor), Levälampi, T. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  20 Mar 2009

  Activity: Talk or presentation › Conference presentation

• Infliximab treatment in patients with rheumatoid arthritis and spondylarthropathies two years drug survival

  Levälampi, T. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  20 Mar 2009

  Activity: Talk or presentation › Conference presentation

• Infliximab treatment in RA and SpA. Drug survival and reasons for discontinuation during two years follow-up

  Levälampi, T. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  29 Jan 2009

  Activity: Talk or presentation › Conference presentation

• Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage

  Koskinen, A. (Speaker), Vuolteenaho, K. (Speaker), Kukkonen, M. (Speaker), Nieminen, R. (Speaker), Moilanen, T. (Speaker) & Moilanen, E. (Speaker)

  29 Jan 2009

  Activity: Talk or presentation › Conference presentation

• Pretreatment levels of adipokines adipsin and leptin are associated with remission rates in early RA (NEO-RaCo study)

  Moilanen, E. (Contributor), Levälampi, T. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  29 Jan 2009

  Activity: Talk or presentation › Conference presentation

• Etanercept and adalimumab treatment in patients with RA and SpA in clinical practice: adverse events and other reasons leading to discotinuation of the treatment

  Kylliäinen, T. (Contributor), Korpela, M. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  23 Jan 2009

  Activity: Talk or presentation › Conference presentation

• Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage

  Koskinen, A. (Speaker), Kukkonen, M. (Speaker), Moilanen, E. (Speaker), Nieminen, R. (Speaker) & Vuolteenaho, K. (Speaker)

  23 Jan 2009

  Activity: Talk or presentation › Conference presentation

• Increased adipsin and low leptin levels are associated with higher remission rates in early RA patients treated with a combination of DMARDs (NEO-RACo study)

  Moilanen, E. (Contributor), Levälampi, T. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  24 Oct 2008

  Activity: Talk or presentation › Conference presentation

• Leptin enhances MMP-1, MMP-3 and MMP-13 production in human OA cartilage

  Vuolteenaho, K. (Contributor), Koskinen, A. (Contributor), Moilanen, E. (Contributor) & Nieminen, R. (Contributor)

  18 Sept 2008

  Activity: Talk or presentation › Conference presentation

• Adipokines, interleukin-6 and metabolic syndrome in patients with inflammatory arthritis

  Vuolteenaho, K. (Contributor), Nieminen, R. (Contributor), Kautiainen, H. (Contributor), Hakala, M. (Contributor) & Moilanen, E. (Contributor)

  24 Jun 2008

  Activity: Talk or presentation › Conference presentation

• Possible role of adipocytokines in the pathogenesis of multiple sclerosis: A Finnish co-twin study

  Hietaharju, A. (Contributor), Kuusisto, H. (Contributor), Nieminen, R. (Contributor), Vuolteenaho, K. (Contributor), Elovaara, I. (Contributor) & Moilanen, E. (Contributor)

  12 Apr 2008

  Activity: Talk or presentation › Conference presentation

• Leptin induces detrimental changes in human OA cartilage. Effects on NO, PGE2, IL-6 and IL-8 production

  Vuolteenaho, K. (Contributor), Koskinen, A. (Contributor), Kukkonen, M. (Contributor), Nieminen, R. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  13 Mar 2008

  Activity: Talk or presentation › Conference presentation

• Etanercept and adalimumab in patients with RA and SpA in clinical practice: adverse events and other reasons leading to discontinuation of the treatment

  Läkinenpi, T. (Contributor), Korpela, M. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  13 Mar 2008

  Activity: Talk or presentation › Conference presentation

• Etanercept and adalimumab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons leading to discontinuation of the treatment

  Levälampi, T. (Contributor) & Vuolteenaho, K. (Contributor)

  31 Jan 2008

  Activity: Talk or presentation › Conference presentation

• Leptin induces IL-6 and IL-8 production in human OA cartilage in a NO-dependent manner

  Koskinen, A. (Contributor), Kukkonen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  30 Jan 2008

  Activity: Talk or presentation › Conference presentation

• Leptin induces detrimental changes in human OA cartilage. Effects on nitric oxide, PGE2, IL-6 and IL-8 production

  Vuolteenaho, K. (Contributor), Koskinen, A. (Contributor), Kukkonen, M. (Contributor), Nieminen, R. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  6 Dec 2007

  Activity: Talk or presentation › Conference presentation

• Effects of iNOS inhibitor 1400W on inflammatory mediators in OA cartilage detected by antibody microarray

  Vuolteenaho, K. (Speaker)

  19 Oct 2006

  Activity: Talk or presentation › Conference presentation

• Effects of iNOS inhibitor 1400W on inflammatory mediators in OA cartilage detected by antibody microarray

  Vuolteenaho, K. (Speaker)

  2 Jul 2006

  Activity: Talk or presentation › Conference presentation

• The effects of nitric oxide on mediators of cartilage metabolism in human OA cartilage detected by antibody microarray

  Vuolteenaho, K. (Speaker)

  23 Mar 2006

  Activity: Talk or presentation › Conference presentation

• The effects of nitric oxide on mediators of cartilage metabolism in human OA cartilage detected by antibody microarray

  Vuolteenaho, K. (Speaker)

  8 Dec 2005

  Activity: Talk or presentation › Conference presentation

• TGF suppresses nitric oxide production in IL-1 treated chondrocytes by enhancing iNOS protein degradation

  Vuolteenaho, K. (Speaker)

  17 Mar 2005

  Activity: Talk or presentation › Conference presentation

• Transforming growth factor (TGF) suppresses nitric oxide (NO) production in interleukin-1 (IL-1) treated chondrocytes by enhancing degradation of the inducible nitric oxide synthase (iNOS) protein

  Vuolteenaho, K. (Speaker)

  20 Jan 2005

  Activity: Talk or presentation › Conference presentation

• Transforming growth factor suppresses nitric oxide production in murine H4 chondrocytes by enhancing degradation of inducible nitric oxide synthase protein

  Vuolteenaho, K. (Speaker)

  2 Dec 2004

  Activity: Talk or presentation › Conference presentation

• Osteoarthritic changes and iNOS expression in experimental osteoarthritis model induced by cruciate ligament transsection in mouse knee

  Vuolteenaho, K. (Speaker)

  18 Mar 2004

  Activity: Talk or presentation › Conference presentation

• Osteoarthritic changes and iNOS expression in experimental osteoarthritis model induced by cruciate ligament transsection in mouse knee

  Vuolteenaho, K. (Speaker)

  12 Oct 2003

  Activity: Talk or presentation › Conference presentation

• Endogenous Cytokine Antagonists Regulate Nitric Oxide Production in Osteoarthritic Cartilage

  Vuolteenaho, K. (Speaker)

  20 Mar 2003

  Activity: Talk or presentation › Conference presentation

• Role of endogenous cytokine antagonists in the regulation of nitric oxide production in osteoarthritic cartilage

  Vuolteenaho, K. (Speaker)

  30 Jan 2003

  Activity: Talk or presentation › Conference presentation